Impact of antibiotic use on carbapenem resistance in Pseudomonas aeruginosa: Is there a role for antibiotic diversity?

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 4, 2013, Pages 1709-1713

  Pluss Suard C ^a,b   Pannatier, A ^a,b   Kronenberg, A ^c   Muhlemann K ^c   Zanetti, G ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ANTIMICROBIAL ACTIVITY; ARTICLE; HOSPITAL CARE; HUMAN; INFORMATION PROCESSING; MULTICENTER STUDY; OBSERVATIONAL STUDY; PREDICTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; SWITZERLAND;

ANTI-BACTERIAL AGENTS; CARBAPENEMS; DRUG RESISTANCE, BACTERIAL; PSEUDOMONAS AERUGINOSA;

EID: 84875134742     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01348-12     Document Type: Article

References (20)

1. Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, Scheld M, Spellberg B, Bartlett J. 2009. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin. Infect. Dis. 48:1-12.
2. El Solh AA, Alhajhusain A. 2009. Update on the treatment of Pseudomonas aeruginosa pneumonia. J. Antimicrob. Chemother. 64:229 -238.
3. Driscoll JA, Brody SL, Kollef MH. 2007. The epidemiology, pathogenesis and treatment of Pseudomonas aeruginosa infections. Drugs 67:351-368.
4. Navon-Venezia S, Ben-Ami R, Carmeli Y. 2005. Update on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting. Curr. Opin. Infect. Dis. 18:306 -313.
5. El Amari EB, Chamot E, Auckenthaler R, Pechere JC, Van Delden C. 2001. Influence of previous exposure to antibiotic therapy on the susceptibility pattern of Pseudomonas aeruginosa bacteremic isolates. Clin. Infect. Dis. 33:1859 -1864.
6. Lepper PM, Grusa E, Reichl H, Hogel J, Trautmann M. 2002. Consumption of imipenem correlates with beta-lactam resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 46:2920 -2925.
7. Rogues AM, Dumartin C, Amadeo B, Venier AG, Marty N, Parneix P, Gachie JP. 2007. Relationship between rates of antimicrobial consumption and the incidence of antimicrobial resistance in Staphylococcus aureus and Pseudomonas aeruginosa isolates from 47 French hospitals. Infect. Control Hosp. Epidemiol. 28:1389 -1395.
8. Rossolini GM, Mantengoli E. 2005. Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa. Clin. Microbiol. Infect. 11(Suppl 4):17-32.
9. Bronzwaer S, Cars O, Buchholz U, Molstad S, Goettsch W, Veldhuijzen IK, Kool JL, Sprenger MJ, Degener JE. 2002. A European study on the relationship between antimicrobial use and antimicrobial resistance. Emerg. Infect. Dis. 8:278 -282.
10. World Health Organization Collaborating Centre for Drug Statistics Methodology. 2011. Guidelines for ATC classification and DDD assignment, 14th ed. World Health Organization, Oslo, Norway.
11. Sandiumenge A, Lisboa T, Gomez F, Hernandez P, Canadell L, Rello J. 2011. Effect of antibiotic diversity on ventilator-associated pneumonia caused by ESKAPE organisms. Chest 140:643- 651.
12. Goel N, Wattal C, Oberoi JK, Raveendran R, Datta S, Prasad KJ. 2011. Trend analysis of antimicrobial consumption and development of resistance in non-fermenters in a tertiary care hospital in Delhi, India. J. Antimicrob. Chemother. 66:1625-1630.
13. Hsueh PR, Chen WH, Luh KT. 2005. Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan. Int. J. Antimicrob. Agents 26:463- 472.
14. Pakyz A, Powell JP, Harpe SE, Johnson C, Edmond M, Polk RE. 2008. Diversity of antimicrobial use and resistance in 42 hospitals in the United States. Pharmacotherapy 28:906 -912.
15. Dellit TH, Owens RC, McGowan JE, Jr, Gerding DN, Weinstein RA, Burke JP, Huskins WC, Paterson DL, Fishman NO, Carpenter CF, Brennan PJ, Billeter M, Hooton TM. 2007. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin. Infect. Dis. 44:159 -177.
16. Van Gastel E, Costers M, Peetermans WE, Struelens MJ. 2010. Nation- wide implementation of antibiotic management teams in Belgian hospitals: a self-reporting survey. J. Antimicrob. Chemother. 65:576 -580.
17. Bal AM, Kumar A, Gould IM. 2010. Antibiotic heterogeneity: from concept to practice. Ann. N. Y. Acad. Sci. 1213:81-91.
18. Bennett KM, Scarborough JE, Sharpe M, Dodds-Ashley E, Kaye KS, Hayward TZ, III, Vaslef SN. 2007. Implementation of antibiotic rotation protocol improves antibiotic susceptibility profile in a surgical intensive care unit. J. Trauma 63:307-311.
19. Brown EM, Nathwani D. 2005. Antibiotic cycling or rotation: a systematic review of the evidence of efficacy. J. Antimicrob. Chemother. 55:6 -9.
20. Morgenstern H. 1995. Ecologic studies in epidemiology: concepts, principles, and methods. Annu. Rev. Public Health 16:61- 81.